Search research articles
Contact Us
Filters
Showing results (281-290 of 290) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 290 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2019
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Susan R Davis, Rodney Baber, Nicholas Panay, et al.
Maturitas
|
September 6, 2019
Global Consensus Position Statement on the use of Testosterone Therapy for Women
Susan R Davis, Rodney Baber, Nicholas Panay, et al.
Mayo Clinic Proceedings
|
March 17, 2018
The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women
Anita H Clayton, Irwin Goldstein, Noel N Kim, et al.
Molecular Genetics & Genomic Medicine
|
January 22, 2020
Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development
Jocelyn A van den Bergen, Gorjana Robevska, Stefanie Eggers, et al.
The Journal of Sexual Medicine
|
October 9, 2010
Responses to the proposed DSM-V changes
Leonard R Derogatis, Ellen Laan, Marieke Brauer, et al.
Menopause (New York, N.Y.)
|
May 11, 2021
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative
Sarah Lensen, Robin J Bell, Janet S Carpenter, et al.
Menopause (New York, N.Y.)
|
April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative
Sarah Lensen, David Archer, Robin J Bell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2010
Postmenopausal hormone therapy: an Endocrine Society scientific statement
Richard J Santen, D Craig Allred, Stacy P Ardoin, et al.
Lancet (London, England)
|
December 11, 2012
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies, Hongchao Pan, Jon Godwin, et al.
Menopause (New York, N.Y.)
|
May 14, 2024
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium
Vincent S Paramanandam, Sarah Lensen, Michaela Gabes, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 290) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 290 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2019
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Susan R Davis, Rodney Baber, Nicholas Panay, et al.
Maturitas
|
September 6, 2019
Global Consensus Position Statement on the use of Testosterone Therapy for Women
Susan R Davis, Rodney Baber, Nicholas Panay, et al.
Mayo Clinic Proceedings
|
March 17, 2018
The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women
Anita H Clayton, Irwin Goldstein, Noel N Kim, et al.
Molecular Genetics & Genomic Medicine
|
January 22, 2020
Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development
Jocelyn A van den Bergen, Gorjana Robevska, Stefanie Eggers, et al.
The Journal of Sexual Medicine
|
October 9, 2010
Responses to the proposed DSM-V changes
Leonard R Derogatis, Ellen Laan, Marieke Brauer, et al.
Menopause (New York, N.Y.)
|
May 11, 2021
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative
Sarah Lensen, Robin J Bell, Janet S Carpenter, et al.
Menopause (New York, N.Y.)
|
April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative
Sarah Lensen, David Archer, Robin J Bell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2010
Postmenopausal hormone therapy: an Endocrine Society scientific statement
Richard J Santen, D Craig Allred, Stacy P Ardoin, et al.
Lancet (London, England)
|
December 11, 2012
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies, Hongchao Pan, Jon Godwin, et al.
Menopause (New York, N.Y.)
|
May 14, 2024
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium
Vincent S Paramanandam, Sarah Lensen, Michaela Gabes, et al.
Page
of 29